AI Prediction Only Drugs
TxGNN model predictions without clinical evidence - research hypotheses for exploration
Evidence Standards
| Level | Definition | Clinical Significance |
|---|---|---|
| L5 | AI prediction only, no clinical evidence | Research hypothesis, requires validation |
Caution: L5 predictions are based on knowledge graph analysis only. They should NOT be used for clinical decision-making and require rigorous validation before any therapeutic application.
Drug List
L5 Level (490 drugs)
| Drug Name | Indications | Link |
|---|---|---|
| Abacavir As Sulfate | 0 | View Report |
| Abaloparatide | 10 | View Report |
| Abiraterone | 10 | View Report |
| Abiraterone Acetate | 0 | View Report |
| Acalabrutinib Maleate | 0 | View Report |
| Acetylsalicylic Acid | 54 | View Report |
| Aclidinium | 10 | View Report |
| Aclidinium Bromide | 50 | View Report |
| Aclidinium Bromide | 0 | View Report |
| Aflibercept | 10 | View Report |
| Agalsidase Beta | 50 | View Report |
| Agalsidase Beta | 10 | View Report |
| Albutrepenonacog Alfa | 10 | View Report |
| Alectinib Hydrochloride | 50 | View Report |
| Alectinib Hydrochloride | 0 | View Report |
| Alendronic Acid | 50 | View Report |
| Alendronic Acid As Sodium Trihydrate | 0 | View Report |
| Alglucosidase Alfa | 50 | View Report |
| Alglucosidase Alfa | 10 | View Report |
| Aliskiren | 10 | View Report |
| Alogliptin | 10 | View Report |
| Alpelisib | 10 | View Report |
| Amifampridine | 10 | View Report |
| Amifampridine Phosphate | 0 | View Report |
| Amikacin Sulfate | 50 | View Report |
| Amikacin Sulfate | 0 | View Report |
| Amlodipine As Amlodipine Besilate | 0 | View Report |
| Anagrelide Hydrochloride | 0 | View Report |
| Anakinra | 10 | View Report |
| Andexanet Alfa | 50 | View Report |
| Andexanet Alfa | 10 | View Report |
| Angiotensin Ii | 10 | View Report |
| Angiotensin Ii Acetate | 50 | View Report |
| Anidulafungin | 10 | View Report |
| Anifrolumab | 10 | View Report |
| Aprepitant | 10 | View Report |
| Arsenic Trioxide | 52 | View Report |
| Artenimol | 10 | View Report |
| Artesunate | 10 | View Report |
| Asenapine Maleate | 50 | View Report |
| Asfotase Alfa | 50 | View Report |
| Asfotase Alfa | 10 | View Report |
| Atosiban | 10 | View Report |
| Atosiban (As Acetate) | 50 | View Report |
| Atropine | 10 | View Report |
| Atropine Sulfate | 50 | View Report |
| Avapritinib | 10 | View Report |
| Avatrombopag | 10 | View Report |
| Avatrombopag Maleate | 50 | View Report |
| Avibactam | 10 | View Report |
| Axicabtagene Ciloleucel | 50 | View Report |
| Axicabtagene Ciloleucel | 10 | View Report |
| Axitinib | 10 | View Report |
| Azilsartan Medoxomil | 10 | View Report |
| Baloxavir Marboxil | 50 | View Report |
| Baloxavir Marboxil | 10 | View Report |
| Baricitinib | 10 | View Report |
| Bedaquiline Fumarate | 50 | View Report |
| Belimumab | 10 | View Report |
| Bempedoic Acid | 50 | View Report |
| Besilesomab | 10 | View Report |
| Bezlotoxumab | 10 | View Report |
| Bimekizumab | 10 | View Report |
| Binimetinib | 10 | View Report |
| Blinatumomab | 10 | View Report |
| Bortezomib | 10 | View Report |
| Bosentan (As Monohydrate) | 50 | View Report |
| Bosutinib (As Monohydrate) | 50 | View Report |
| Botulinum Toxin Type A | 50 | View Report |
| Botulinum Toxin Type A | 10 | View Report |
| Brentuximab Vedotin | 51 | View Report |
| Brigatinib | 10 | View Report |
| Brinzolamide | 10 | View Report |
| Brodalumab | 10 | View Report |
| Brolucizumab | 10 | View Report |
| Bupivacaine | 10 | View Report |
| Burosumab | 10 | View Report |
| Cabotegravir | 10 | View Report |
| Caffeine | 10 | View Report |
| Canagliflozin | 10 | View Report |
| Canakinumab | 10 | View Report |
| Capecitabine | 10 | View Report |
| Caplacizumab | 10 | View Report |
| Capsaicin | 10 | View Report |
| Carbidopa | 10 | View Report |
| Carfilzomib | 10 | View Report |
| Carglumic Acid | 50 | View Report |
| Carglumic Acid | 10 | View Report |
| Cariprazine | 10 | View Report |
| Caspofungin (As Acetate) | 50 | View Report |
| Catridecacog | 10 | View Report |
| Catumaxomab | 10 | View Report |
| Ceftaroline Fosamil | 50 | View Report |
| Ceftaroline Fosamil | 10 | View Report |
| Ceftolozane | 10 | View Report |
| Cemiplimab | 10 | View Report |
| Ceritinib | 10 | View Report |
| Cerliponase Alfa | 50 | View Report |
| Cerliponase Alfa | 10 | View Report |
| Certolizumab Pegol | 52 | View Report |
Showing first 100 of 490 drugs. See Full Drug List for all.
Statistics
| Metric | Value |
|---|---|
| Total L5 Drugs | 490 |
| Total Predictions | 32,368 |
| Unique Indications | 4,570 |
Validation Pathway
To upgrade from L5 to higher evidence levels:
L5 (AI Prediction)
↓ Literature search
L4 (Preclinical/Mechanistic)
↓ Observational studies
L3 (Cohort/Case-control)
↓ Phase 2 trials
L2 (Single RCT)
↓ Multiple Phase 3 trials
L1 (Strong Evidence)
Download L5 Data
All L5 predictions available at: